Outpatient Clinic For Individual Practice For Specialized Outpatient Medical Care In Cardiology Dr. Gonovska EOOD

Verified siteinfo

Bulgaria Ulitsa Shipka 23, 4023 Plovdiv, Bulgaria

1 trial recruiting
Heart failure with preserved ejection fraction · Obesity · Arteriosclerosis
Adult patients

About Specializations

Outpatient Clinic For Individual Practice For Specialized Outpatient Medical Care In Cardiology Dr. Gonovska EOOD in Plovdiv, Bulgaria specialises in clinical trials of conditions such as Heart failure with preserved ejection fraction, Obesity, Arteriosclerosis, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Disease Research

At the Outpatient Clinic for Individual Practice for Specialized Outpatient Medical Care in Cardiology Dr. Gonovska EOOD, investigators are conducting studies aimed at improving outcomes for patients with atherosclerotic cardiovascular disease and various forms of heart failure.

Evaluation of new therapy for heart failure with preserved ejection fraction
Assessment of treatment impact on heart failure with mildly reduced ejection fraction
Investigation of cardiovascular risk reduction in overweight or obese patients
Integration of therapies with background SGLT2 inhibitor use

The trials compare investigational agents to placebo to demonstrate superiority in lowering cardiovascular death, urgent heart‑failure visits, and first major adverse cardiac events, providing potential new options for individuals with established ASCVD and metabolic risk factors.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Ulitsa Shipka 234023 PlovdivBulgaria

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 4
Partner status: Verified site

More sites in Plovdiv Bulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Heart failure with preserved ejection fraction

Recruiting

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug